牛のFFAR2/GPR43の内生リガンドは,独特の薬理学的特性を有する
Tainara Cristina Michelotti1, Valérie Lamothe2, Frédéric Jean-Alphonse3,4
1INRAE, Université Clermont Auvergne, VetAgro Sup, UMR Herbivores, Saint-Genès-Champanelle, France.
Frontiers in cell and developmental biology
|September 5, 2025
まとめ
牛のフリー脂肪酸受容体2 (bFFAR2) のシグナリングは,短鎖および中鎖の脂肪酸によって活性化されます. 脂肪酸の構造,特に炭素の長さと分岐は,bFFAR2の効能と下流効果に影響する.
科学分野:
- 薬理学と分子生物学
- Gタンパク質結合受容体 (GPCR) 信号伝達
- 脂質代謝とシグナル伝達
背景:
- 自由脂肪酸 (FFAs) は,GPCRのサブファミリーである自由脂肪酸受容体 (FFARs) の内生リガンドである.
- FFAR2は様々な生理学的プロセスに作用し,潜在的治療標的となる.
- 牛のFFAR2 (bFFAR2) の薬理学的特徴は不完全である.
研究 の 目的:
- bFFAR2信号の活性化と調節を,一連のFFAによって調査する.
- bFFAR2における短鎖および中鎖のFFAの構造活動関係を明らかにする.
主な方法:
- bFFAR2の活性度を評価するために,HEK293A細胞を使用した.
- Gタンパク質結合 (Gαi/Gαq) とβ-アレスティン2募集を測定するために,生物発光共振エネルギー転送 (BRET) 測定法を使用した.
- 転写活性化 (SREとNFAT-RE) を評価するために,ルシフェラーゼレポーターアッセイを使用した.
主要な成果:
- bFFAR2はGαiとGαqとの二重結合を示し,FFAsをC8: 0まで刺激するとβ-アレスティン2を誘導する.
- 4−7炭素と3メチルブタノ酸を持つFFAは,bFFAR2を活性化するのに最も高い効能を示した.
- 2メチルプロパノ酸 (2MP) は,初期エンドソームトラフィックなしに,最小のβ-アレスティン2活性と限られた受容体内化を示した.
結論:
- bFFAR2の活性化とシグナリングは,直鎖FFAの炭素鎖長と,枝分かれFFAのメチル群の位置によって差異的に調節される.
- bFFAR2を調節する標的治療法の開発には,これらの構造-活性関係を理解することが不可欠です.
- 様々なFFAによるbFFAR2活性化のダウンストリームの結果を完全に描写するには,さらなる研究が必要です.
関連する概念動画
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
G Protein-coupled Receptors
13.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.2K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Transducer Mechanism: G Protein–Coupled Receptors
2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.4K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Drug-Receptor Interactions
5.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.9K


